The V Foundation for Cancer Research Eclipses the $75.1 Million Mark in Total Fundraising to Address Cancer Health Inequities
Read moreFunded Grants
The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help men, women and children diagnosed with cancer.
Featured Grants
Christina Ferrer, PhD
Investigating Purine Salvage Dependencies in CDKN2A-deleted Pancreatic Meta...
2024
Abhijit Parolia, PhD
Co-targeting NSD1/2 paralogs in AR-driven metastatic castration-resistant p...
2024
Anthony Law, MD, PhD
Early detection of Laryngeal Cancer using Machine Learning
2024
Benjamin Barwick, PhD
Targeting Transcriptional Co-Activators to Overcome Therapeutic Resistance ...
2024
Elizabeth Wasmuth, PhD
Uncovering Therapeutic Vulnerabilities in Oncogenic Hormone Receptor Signal...
2024
Rachel Niec, MD, PhD, MS
Deciphering Inter- and Intra-Tissue Communication Networks in Colitis and C...
2024
Xin Cai, MD, PhD
Targeting Metabolite Signaling in Cancer Therapy
2024
Kathleen Mulvaney, PhD
Identifying novel drug combinations to overcome therapeutic resistance in C...
2024
Tae Kon Kim, MD, PhD
Immune evasion mediated by LAIR1-collagen pathway in high risk myelodysplas...
2024
Brandon Faubert, PhD
Elucidating the Role of Fatty Acid Metabolism During Lung Cancer Progression
2024
Defne Bayik, PhD
Dipeptidyl peptidase 4 targeting to reinvigorate CD8+ T cells in glioblastoma
2024
Aram Modrek, MD, PhD
Decoding Glioblastoma Treatment Escape Mechanisms: Integrative Single-Cell ...
2024
Brian Miller, MD, PhD
Dissecting metabolic vulnerabilities of tumor- associated macrophages to im...
2024
Gabriel Griffin, MD
Harnessing Endogenous Retroviruses to Overcome Immunotherapy Resistance in ...
2024
Daniel Matson, MD, PhD
GATA2 Enables a Personalized Medicine Approach to Endometrial Serous Carcinoma
2024